MedTrace Logo

Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer

NCT03436329 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-10-12

No results posted yet for this study

Summary

The purpose of this study is to assess the impact of the sequence of vessel interruption in lung cancer patients on tumor cell spread and patient survival by using peripheral blood circulating tumor cells.

Conditions

Interventions

PROCEDURE

Vein ligation first

During this procedure, patients undergo lobectomy with the pulmonary vein ligated first.

PROCEDURE

Artery ligation first

During this procedure, patients undergo lobectomy with the pulmonary artery ligated first.

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Lunxu Liu, M.D.,Ph.D. · West China Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-05-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03436329 on ClinicalTrials.gov